Staahl Brett bought SCTX
July 23, 2026 · Form 4 insider transaction
Staahl Brett bought 19,385 shares of Scribe Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,385
Price
$0.00
Total value
N/A
InsiderStaahl Brett
Role10% owner
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 23, 2026
Filing dateJuly 28, 2026
Shares owned after19,385
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options will vest as to 1/48 of the total shares monthly over four years, with the first tranche scheduled to vest on August 23, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.